STAMFORD, Conn.—Private equity firm Atlantic Street Capital
announced Thursday that its portfolio company, Lombart Instrument
, a distributor of ophthalmic instruments to ophthalmologists and optometrists based in Norfolk, Va., has acquired Enhanced Medical Services
(EMS), a distributor of pre-owned ophthalmic instruments in the U.S. The terms of the transaction were not announced. Founded in 2007 by CEO Tony Genovese, EMS provides pre-owned eyecare equipment and offers an array of diagnostic, laser, and classical solutions to the eyecare industry.
EMS also carries a wide selection of new equipment from the top manufacturers in the industry and offers comprehensive customer service. The company is headquartered in St. Louis.
Scott Lombart, chief commercial officer of Lombart, said, “The addition of EMS increases our product offering and our customer base but, most valuably, it gives our organization the opportunity to work more aggressively within a doctor's budget. EMS's relationships, expertise, and inventory provide us additional solutions for practices with different instrumentation needs.”
Genovese joins Lombart in a dual role—as EVP of Lombart's National Accounts and as the EVP of the pre-owned business—and his team will supplement Lombart's existing team.
"As founder of the company, I was determined to find a partner that would strengthen our operations and have an immediate impact on our ability to better service clients and patients,” said Genovese. “Lombart is an exclusive eyecare instrument provider and is that ideal fit for us as we look to deliver even better service to our customers. I look forward to working with this premier organization to deliver quality and affordable eyecare products.”
Andy Wilkins, managing partner of Atlantic Street Capital, added, "Since our acquisition of Lombart in 2016 we have steadily built the business through organic growth, as well as expanded into Canada with the earlier acquisition of Innova. The addition of EMS is another significant investment to strengthen Lombart's position as a key partner for its customers, further extending our ability to deliver a breadth of clinical solutions."